For the Inventor, By the Inventor

Enter assignee name

Marseilles, France

Innate Pharma S.a.s.

USPTO Granted Patents = 10

CIPO Patents = 1

EPO Patents = 1

Trademarks = 1

Forward Citations = 87

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Peter Andreas Nicolai Reumert Wagtmann (8 out of 17 patents)

Alessandro Moretta (5 out of 21 patents)

Francois Romagne (5 out of 12 patents)

4. Anders Svensson (5 out of 10 patents)

5. Stefan Zahn (5 out of 11 patents)

6. Pascale Andre (3 out of 18 patents)

7. Kristian Kjaergaard (3 out of 13 patents)

8. Joakim Glamann (3 out of 3 patents)

9. Pieter Spee (3 out of 4 patents)

10. Mariella Della Chiesa (3 out of 6 patents)

11. Ivan Svendsen (3 out of 5 patents)

12. Søren Berg Padkær (3 out of 7 patents)

13. Laurent Gauthier (2 out of 41 patents)

14. Kristian Kjærgaard (2 out of 5 patents)

15. Matthias Thorolfsson (2 out of 2 patents)

10 patents: Sort by Forward Citations

1. 10253095 - Anti-KIR combination treatments and methods (2019-04-09),

2. 9333255 - Methods of enhancing antibody-based antiviral therapies by administering KIR2DL-binding antibodies (2016-05-10),

3. 9018366 - KIR-binding agents and methods of use thereof (2015-04-28),

4. 8981065 - Human anti-KIR antibodies (2015-03-17),

5. 8614307 - Nucleic acids encoding human anti-kir antibodies (2013-12-24),

6. 8551483 - Methods of treating viral infections by administering KIR2DL-binding antibodies (2013-10-08),

7. 8388970 - KIR-binding agents and methods of use thereof (2013-03-05),

8. 8119775 - Human anti-KIR antibodies (2012-02-21),

9. 7517966 - Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same (2009-04-14),

10. 6979546 - Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same (2005-12-27),

Innate Pharma S.a.s. is a clinical-stage biotechnology company dedicated to improving cancer treatment through the development of innovative immunotherapy products. The company's pipeline includes a range of first-in-class antibodies that target the immune system to fight cancer. With a focus on activating the body's natural defenses, Innate Pharma aims to provide better outcomes for patients with various types of cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

10 Patents

#9 in Marseilles

#1,665 in France

#54,268 in the World

Marseilles, France

Innate Pharma S.a.s.

Forward Citations = 87

26 inventors:

Peter Andreas Nicolai Reumert Wagtmann (8 out of 17 patents)

Alessandro Moretta (5 out of 21 patents)

Francois Romagne (5 out of 12 patents)

4. Anders Svensson (5 out of 10 patents)

5. Stefan Zahn (5 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…